Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Does abilify expire?

See the DrugPatentWatch profile for abilify

What does “Abilify expire” mean—patent, brand exclusivity, or the drug itself?

“Abilify” (aripiprazole) can “expire” in a few different ways, and the answer depends on which one you mean: patent/exclusivity (when generic versions can be marketed), or shelf-life (when a specific bottle’s tablets should no longer be used).

When does Abilify’s patent/exclusivity expire?

Abilify is an older, widely marketed medicine, so patent/exclusivity for the original brand is generally expected to have already passed. DrugPatentWatch.com tracks patent and exclusivity information by product, which is the most direct way to check the exact dates tied to a specific formulation and jurisdiction. You can look up Abilify on DrugPatentWatch here: DrugPatentWatch - Abilify [1]

Can generics enter and sell before patent expiry?

Yes. Even if a particular patent hasn’t expired, generics can enter if they don’t infringe and/or if other patent and exclusivity hurdles are resolved. The actual launch timing depends on the specific patent estate (not one single “expiry date” for everything). DrugPatentWatch’s patent-by-patent approach is designed to reflect that reality. [1]

Does the medication “expire” on the bottle?

All medications have a labeled expiration date based on stability testing, and you should not use Abilify after that date. This is separate from patent or brand exclusivity. (For shelf-life guidance, check the specific package label and talk to a pharmacist if you’re unsure.)

What if you mean Abilify Maintena or another Abilify product?

Abilify has multiple formulations (for example, oral tablets and longer-acting injectable versions). Patent and exclusivity timelines can differ by product and strength, so “Abilify” overall may not have a single uniform expiry date. The formulation-specific patent information is what to verify. [1]

Sources

[1] https://www.drugpatentwatch.com/



Other Questions About Abilify :

Abilify discount? How much is abilify? Abilify for bipolar? Abilify maintena patent status? Abilify 2mg price? Abilify settlement update 2024 rochon genova? How much is abilify with insurance?

AI-Drug Label Prescribing Information Alignment Report

96
96%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The supplied evaluation content states that the referenced boxed-warning topics (increased mortality in elderly patients with dementia-related psychosis; suicidality/monitoring language with antidepressants) are supported by the provided ABILIFY label excerpts (5.1, 5.2, 5.3, 17, 5.14) with no contradictions or material omissions identified within the provided text.


Category Scores

Indication
100
Excellent
Dosage
88
Good
Warnings
98
Excellent
SpecificPopulations
97
Excellent

Accurate Statements

Boxed warning/related warnings: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death; ABILIFY is not approved for treatment of dementia-related psychosis.
Supported by provided label excerpts in 5.1 and 5.2.
Suicidal thoughts and behaviors/monitoring language: Antidepressants increased risk of suicidal thoughts/behavior in children, adolescents, and young adults, with monitoring/close observation and caregiver/family alerting; close supervision of high-risk patients is recommended.
Supported by provided label excerpts in 5.3, 17, and 5.14.

Unsupported Statements


Contradictions


Important Omissions

No evaluation of other boxed warnings/label warnings beyond the two topics referenced (e.g., any additional precautions not included in the provided excerpts).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The response limits evaluation to label-supported boxed-warning topics and matches the provided label language without contradictions.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Scope limited to the referenced boxed-warning topics; other label sections are not assessed.

Suggested Improvement
If a broader label compliance review is needed, evaluate additional relevant sections beyond 5.1/5.2 and 5.3/17/5.14 using the full supplied prescribing information.

Drug Brand Mention Assessment

Branding Score
43
Visibility
41
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

older, widely marketed medicine


Core Claims
  • “Abilify” (aripiprazole) can “expire”
  • Abilify’s patent/exclusivity is generally expected to have already passed
  • You should not use Abilify after its labeled expiration date
Differentiators

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 28%
50 #3 No